Reports
Reports
Sale
The global enteral feeding formulas market attained a value of about USD 8.14 billion in 2023. The market is further expected to grow in the forecast period of 2024-2032 at a CAGR of 7.1% to reach nearly USD 15.22 billion by 2032.
Enteral Feeding Formulas Market Size
Enteral Feeding Formulas Market Growth
Enteral Feeding Formulas Companies
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Opportunities and Challenges in the Market
8 Global Enteral Feeding Formulas Market Analysis
8.1 Key Industry Highlights
8.2 Global Enteral Feeding Formulas Historical Market (2018-2023)
8.3 Global Enteral Feeding Formulas Market Forecast (2024-2032)
8.4 Global Enteral Feeding Formulas Market by Product
8.4.1 Standard Formula
8.4.1.1 Historical Trend (2018-2023)
8.4.1.2 Forecast Trend (2024-2032)
8.4.2 Disease Specific Formula
8.4.2.1 Historical Trend (2018-2023)
8.4.2.2 Forecast Trend (2024-2032)
8.5 Global Enteral Feeding Formulas Market by Flow Type
8.5.1 Intermittent Feeding Flow
8.5.1.1 Historical Trend (2018-2023)
8.5.1.2 Forecast Trend (2024-2032)
8.5.2 Continuous Feeding Flow
8.5.2.1 Historical Trend (2018-2023)
8.5.2.2 Forecast Trend (2024-2032)
8.6 Global Enteral Feeding Formulas Market by Stage
8.6.1 Adults
8.6.1.1 Historical Trend (2018-2023)
8.6.1.2 Forecast Trend (2024-2032)
8.6.2 Paediatrics
8.6.2.1 Historical Trend (2018-2023)
8.6.2.2 Forecast Trend (2024-2032)
8.7 Global Enteral Feeding Formulas Market by Indication
8.7.1 Alzheimer’s
8.7.1.1 Historical Trend (2018-2023)
8.7.1.2 Forecast Trend (2024-2032)
8.7.2 Nutrition Deficiency
8.7.2.1 Historical Trend (2018-2023)
8.7.2.2 Forecast Trend (2024-2032)
8.7.3 Cancer Care
8.7.3.1 Historical Trend (2018-2023)
8.7.3.2 Forecast Trend (2024-2032)
8.7.4 Diabetes
8.7.4.1 Historical Trend (2018-2023)
8.7.4.2 Forecast Trend (2024-2032)
8.7.5 Chronic Kidney Diseases
8.7.5.1 Historical Trend (2018-2023)
8.7.5.2 Forecast Trend (2024-2032)
8.7.6 Orphan Diseases
8.7.6.1 Historical Trend (2018-2023)
8.7.6.2 Forecast Trend (2024-2032)
8.7.7 Dysphagia
8.7.7.1 Historical Trend (2018-2023)
8.7.7.2 Forecast Trend (2024-2032)
8.7.8 Pain Management
8.7.8.1 Historical Trend (2018-2023)
8.7.8.2 Forecast Trend (2024-2032)
8.7.9 Malabsorption/GI Disorder/Diarrhoea
8.7.9.1 Historical Trend (2018-2023)
8.7.9.2 Forecast Trend (2024-2032)
8.7.10 Others
8.8 Global Enteral Feeding Formulas Market by End User
8.8.1 Hospitals
8.8.1.1 Historical Trend (2018-2023)
8.8.1.2 Forecast Trend (2024-2032)
8.8.1.3 Breakup by Type
8.8.1.3.1 Cardiology
8.8.1.3.2 Neurology
8.8.1.3.3 Critical Care (ICU)
8.8.1.3.4 Oncology
8.8.1.3.5 Others
8.8.2 Home Care
8.8.2.1 Historical Trend (2018-2023)
8.8.2.2 Forecast Trend (2024-2032)
8.9 Global Enteral Feeding Formulas Market by Region
8.9.1 North America
8.9.1.1 Historical Trend (2018-2023)
8.9.1.2 Forecast Trend (2024-2032)
8.9.2 Europe
8.9.2.1 Historical Trend (2018-2023)
8.9.2.2 Forecast Trend (2024-2032)
8.9.3 Asia Pacific
8.9.3.1 Historical Trend (2018-2023)
8.9.3.2 Forecast Trend (2024-2032)
8.9.4 Latin America
8.9.4.1 Historical Trend (2018-2023)
8.9.4.2 Forecast Trend (2024-2032)
8.9.5 Middle East and Africa
8.9.5.1 Historical Trend (2018-2023)
8.9.5.2 Forecast Trend (2024-2032)
9 North America Enteral Feeding Formulas Market Analysis
9.1 United States of America
9.1.1 Historical Trend (2018-2023)
9.1.2 Forecast Trend (2024-2032)
9.2 Canada
9.2.1 Historical Trend (2018-2023)
9.2.2 Forecast Trend (2024-2032)
10 Europe Enteral Feeding Formulas Market Analysis
10.1 United Kingdom
10.1.1 Historical Trend (2018-2023)
10.1.2 Forecast Trend (2024-2032)
10.2 Germany
10.2.1 Historical Trend (2018-2023)
10.2.2 Forecast Trend (2024-2032)
10.3 France
10.3.1 Historical Trend (2018-2023)
10.3.2 Forecast Trend (2024-2032)
10.4 Italy
10.4.1 Historical Trend (2018-2023)
10.4.2 Forecast Trend (2024-2032)
10.5 Others
11 Asia Pacific Enteral Feeding Formulas Market Analysis
11.1 China
11.1.1 Historical Trend (2018-2023)
11.1.2 Forecast Trend (2024-2032)
11.2 Japan
11.2.1 Historical Trend (2018-2023)
11.2.2 Forecast Trend (2024-2032)
11.3 India
11.3.1 Historical Trend (2018-2023)
11.3.2 Forecast Trend (2024-2032)
11.4 ASEAN
11.4.1 Historical Trend (2018-2023)
11.4.2 Forecast Trend (2024-2032)
11.5 Australia
11.5.1 Historical Trend (2018-2023)
11.5.2 Forecast Trend (2024-2032)
11.6 Others
12 Latin America Enteral Feeding Formulas Market Analysis
12.1 Brazil
12.1.1 Historical Trend (2018-2023)
12.1.2 Forecast Trend (2024-2032)
12.2 Argentina
12.2.1 Historical Trend (2018-2023)
12.2.2 Forecast Trend (2024-2032)
12.3 Mexico
12.3.1 Historical Trend (2018-2023)
12.3.2 Forecast Trend (2024-2032)
12.4 Others
13 Middle East and Africa Enteral Feeding Formulas Market Analysis
13.1 Saudi Arabia
13.1.1 Historical Trend (2018-2023)
13.1.2 Forecast Trend (2024-2032)
13.2 United Arab Emirates
13.2.1 Historical Trend (2018-2023)
13.2.2 Forecast Trend (2024-2032)
13.3 Nigeria
13.3.1 Historical Trend (2018-2023)
13.3.2 Forecast Trend (2024-2032)
13.4 South Africa
13.4.1 Historical Trend (2018-2023)
13.4.2 Forecast Trend (2024-2032)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Value Chain Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Company Profiles
16.2.1 Danone S.A.
16.2.1.1 Company Overview
16.2.1.2 Product Portfolio
16.2.1.3 Demographic Reach and Achievements
16.2.1.4 Certifications
16.2.2 Nestlé S.A.
16.2.2.1 Company Overview
16.2.2.2 Product Portfolio
16.2.2.3 Demographic Reach and Achievements
16.2.2.4 Certifications
16.2.3 Abbott Nutrition
16.2.3.1 Company Overview
16.2.3.2 Product Portfolio
16.2.3.3 Demographic Reach and Achievements
16.2.3.4 Certifications
16.2.4 Mead Johnson & Company, LLC
16.2.4.1 Company Overview
16.2.4.2 Product Portfolio
16.2.4.3 Demographic Reach and Achievements
16.2.4.4 Certifications
16.2.5 Fresenius Kabi AG
16.2.5.1 Company Overview
16.2.5.2 Product Portfolio
16.2.5.3 Demographic Reach and Achievements
16.2.5.4 Certifications
16.2.6 Others
17 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Global Enteral Feeding Formulas Market: Key Industry Highlights, 2018 and 2032
2. Global Enteral Feeding Formulas Historical Market: Breakup by Product (USD Billion), 2018-2023
3. Global Enteral Feeding Formulas Market Forecast: Breakup by Product (USD Billion), 2024-2032
4. Global Enteral Feeding Formulas Historical Market: Breakup by Flow Type (USD Billion), 2018-2023
5. Global Enteral Feeding Formulas Market Forecast: Breakup by Flow Type (USD Billion), 2024-2032
6. Global Enteral Feeding Formulas Historical Market: Breakup by Stage (USD Billion), 2018-2023
7. Global Enteral Feeding Formulas Market Forecast: Breakup by Stage (USD Billion), 2024-2032
8. Global Enteral Feeding Formulas Historical Market: Breakup by Indication (USD Billion), 2018-2023
9. Global Enteral Feeding Formulas Market Forecast: Breakup by Indication (USD Billion), 2024-2032
10. Global Enteral Feeding Formulas Historical Market: Breakup by End User (USD Billion), 2018-2023
11. Global Enteral Feeding Formulas Market Forecast: Breakup by End User (USD Billion), 2024-2032
12. Global Enteral Feeding Formulas Historical Market: Breakup by Region (USD Billion), 2018-2023
13. Global Enteral Feeding Formulas Market Forecast: Breakup by Region (USD Billion), 2024-2032
14. North America Enteral Feeding Formulas Historical Market: Breakup by Country (USD Billion), 2018-2023
15. North America Enteral Feeding Formulas Market Forecast: Breakup by Country (USD Billion), 2024-2032
16. Europe Enteral Feeding Formulas Historical Market: Breakup by Country (USD Billion), 2018-2023
17. Europe Enteral Feeding Formulas Market Forecast: Breakup by Country (USD Billion), 2024-2032
18. Asia Pacific Enteral Feeding Formulas Historical Market: Breakup by Country (USD Billion), 2018-2023
19. Asia Pacific Enteral Feeding Formulas Market Forecast: Breakup by Country (USD Billion), 2024-2032
20. Latin America Enteral Feeding Formulas Historical Market: Breakup by Country (USD Billion), 2018-2023
21. Latin America Enteral Feeding Formulas Market Forecast: Breakup by Country (USD Billion), 2024-2032
22. Middle East and Africa Enteral Feeding Formulas Historical Market: Breakup by Country (USD Billion), 2018-2023
23. Middle East and Africa Enteral Feeding Formulas Market Forecast: Breakup by Country (USD Billion), 2024-2032
24. Global Enteral Feeding Formulas Market Structure
In 2023, the global enteral feeding formulas market attained a value of nearly USD 8.14 billion.
The market is projected to grow at a CAGR of 7.1% between 2024 and 2032.
The market is estimated to witness a healthy growth in the forecast period of 2024-2032 to reach about USD 15.22 billion by 2032.
The market is being driven by surging demand for enteral feeding formulas by patients affected from chronic diseases like cancer, cardiovascular disorders, and kidney diseases, among others.
Robust research and development and the corresponding development of new products to cater the increasing demand for enteral feeding formulas are pushing the growth of the market.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The major products of enteral feeding formulas are standard formula and disease specific formulas.
The various flow types of enteral feeding formulas are intermittent feeding flow and continuous feeding flow.
The several stages of enteral feeding formulas are adults and paediatrics.
The major indications of enteral feeding formulas are Alzheimer’s, nutrition deficiency, cancer care, diabetes, chronic kidney diseases, orphan diseases, dysphagia, pain management, and malabsorption/GI disorder, and diarrhoea, among others.
The significant end users of enteral feeding formulas are hospitals and home care.
The major players in the industry are Danone S.A., Nestlé S.A., Abbott Nutrition, Mead Johnson & Company, LLC, and Fresenius Kabi AG, among others.
The global enteral feeding formulas market attained a value of nearly USD 8.14 billion in 2023, driven by the rising number of chronic diseases. Aided by expansion in product portfolios, the market is expected to witness a further growth in the forecast period of 2024-2032, growing at a CAGR of 7.1% to reach about USD 15.22 billion by 2032.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its products, the market can be divided into standard formula and disease specific formulas. On the basis of flow type, the market can be segmented into intermittent feeding flow and continuous feeding flow. The market, based on stage, can be categorised into adults and paediatrics. Based on indication, the market can be categorised into Alzheimer’s, nutrition deficiency, cancer care, diabetes, chronic kidney diseases, orphan diseases, dysphagia, pain management, and malabsorption/GI disorder, and diarrhoea, among others. On the basis of end users, the market can be classified into hospitals and home care. The major regional markets for enteral feeding formulas are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Danone S.A., Nestlé S.A., Abbott Nutrition, Mead Johnson & Company, LLC, and Fresenius Kabi AG, among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Datasheet
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.